Meningococcal disease: Can we predict the unpredictable?
Med Clin (Barc). 2020 Jan 10;154(1):20-22.
doi: 10.1016/j.medcli.2019.04.035.
Epub 2019 Jul 23.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Pediatría, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, España; Grupo de Genética, Vacunas, Infecciones y Pediatría, Instituto de Investigación Sanitaria de Santiago, Universidad de Santiago de Compostela, Santiago de Compostela, España. Electronic address: federico.martinon.torres@sergas.es.
- 2 Servicio de Medicina Preventiva y Epidemiología, Hospital Clinic - Universidad de Barcelona - ISGlobal.
No abstract available
MeSH terms
-
Adolescent
-
Cost-Benefit Analysis
-
Humans
-
Immunization Schedule*
-
Infant
-
Meningococcal Infections / prevention & control*
-
Meningococcal Vaccines / administration & dosage*
-
Meningococcal Vaccines / immunology
-
Neisseria meningitidis, Serogroup B / immunology
-
Neisseria meningitidis, Serogroup W-135 / immunology
-
Neisseria meningitidis, Serogroup Y / immunology
-
Spain
-
United Kingdom
-
Vaccination / statistics & numerical data
-
Vaccines, Conjugate / administration & dosage
-
Vaccines, Conjugate / immunology
Substances
-
Meningococcal Vaccines
-
Vaccines, Conjugate